Related Experiment Video
Updated: Jul 3, 2026
12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations
Nuhad Abou Zeid1, Nuhad Abou Zeid, M Tariq Bhatti
1Department of Ophthalmology, Duke University Eye Center and Duke University Medical Center, Durham, NC 27710, USA.
The Neurologist
|July 12, 2008
Summary
Optic neuritis (ON) is an inflammatory optic nerve condition. Early treatment with disease-modifying drugs can reduce the risk of developing multiple sclerosis (MS), but precise diagnosis and timing remain key.
Area of Science:
- Neuroscience
- Ophthalmology
- Immunology
Background:
- Optic neuritis (ON) is an acute inflammatory demyelinating disorder of the optic nerve, primarily affecting young adults.
- It can occur in isolation or as a precursor to central nervous system demyelinating diseases like multiple sclerosis (MS) or neuromyelitis optica.
- Accurate diagnosis and risk assessment are crucial for managing ON and its potential progression to MS.
Purpose of the Study:
- To review the current understanding of optic neuritis (ON) as a clinically isolated syndrome (CIS).
- To evaluate the impact of therapeutic interventions on visual recovery and MS conversion.
- To highlight the need for improved diagnostic tools for predicting MS conversion and disease severity.
Main Methods:
- Review of clinical presentations and outcomes of optic neuritis.
- Analysis of data from prospective, randomized, double-blinded, placebo-controlled studies on disease-modifying drugs (DMDs) in CIS.
- Evaluation of corticosteroid treatment efficacy in ON and MS relapses.
Main Results:
- Intravenous methylprednisolone accelerates visual recovery in ON but does not alter long-term visual outcomes.
- Disease-modifying drugs, such as interferons-beta, reduce the risk of MS conversion in high-risk CIS patients.
- Visual prognosis for ON is generally excellent, irrespective of corticosteroid treatment.
Conclusions:
- Optic neuritis is the most studied CIS, with most patients experiencing excellent visual recovery.
- Initiating disease-modifying therapy during a CIS event can decrease the rate of MS development.
- Further advancements in diagnostic tools are necessary for accurate MS conversion prediction and personalized treatment strategies in ON.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...